Combination of Linagliptin and Empagliflozin Preserves Cardiac Systolic Function in an Ischemia-Reperfusion Injury Mice With Diabetes Mellitus

BACKGROUND: Sodium-glucose co-transporter 2 inhibitor (SGLT2i) and dipeptidyl peptidase 4 inhibitor (DPP4i) are oral hypoglycemic agents. Although SGLT2i has been shown having the beneficial effects on heart failure in basic and clinical studies, the combined effects of SGLT2i and DPP4i have not bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Ideishi, Akihito, Suematsu, Yasunori, Tashiro, Kohei, Morita, Hidetaka, Kuwano, Takashi, Tomita, Sayo, Nakai, Kanji, Miura, Shin-ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935637/
https://www.ncbi.nlm.nih.gov/pubmed/33738012
http://dx.doi.org/10.14740/cr1194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935637/
https://www.ncbi.nlm.nih.gov/pubmed/33738012
http://dx.doi.org/10.14740/cr1194

Ejemplares similares